Novel agents in the treatment of chronic lymphocytic leukemia: a review about the future.
about
New developments in the treatment of chronic lymphocytic leukemia: role of obinutuzumabPI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors.Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.Combination of galectin inhibitor GCS-100 and BH3 mimetics eliminates both p53 wild type and p53 null AML cells.Efficacy of lenalidomide in relapsed/refractory chronic lymphocytic leukemia patient: a systematic review and meta-analysis.Potential Use of Flavopiridol in Treatment of Chronic Diseases.
P2860
Novel agents in the treatment of chronic lymphocytic leukemia: a review about the future.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Novel agents in the treatment of chronic lymphocytic leukemia: a review about the future.
@en
type
label
Novel agents in the treatment of chronic lymphocytic leukemia: a review about the future.
@en
prefLabel
Novel agents in the treatment of chronic lymphocytic leukemia: a review about the future.
@en
P1476
Novel agents in the treatment of chronic lymphocytic leukemia: a review about the future
@en
P2093
Anjali Varma Desai
Hassan El-Bakkar
P304
P356
10.1016/J.CLML.2014.09.007
P407
P50
P577
2014-09-30T00:00:00Z